05 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/curis-enters-into-agreement-for-emavusertib--pembrolizumab-combination-study-in-melanoma-302005577.html
07 Jul 2023
// Paul Schloesser ENDPTS
https://endpts.com/fda-lifts-partial-hold-on-curis-phi-ii-leukemia-study-as-biotech-raises-15m/
07 Jul 2023
// ONCLIVE
https://www.onclive.com/view/fda-lifts-partial-clinical-hold-on-takeaim-leukemia-trial-of-emavusertib-in-aml-mds
04 Apr 2023
// Nick Paul Taylor FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/fda-puts-curis-leukemia-trial-partial-hold-after-patient-death-spurs-review-muscle
31 Aug 2022
// Gabrielle Masson FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/fda-sparks-hope-curis-lets-biotech-resume-enrollment-part-phase-12-leukemia-study
19 Aug 2022
// Jim Cornall LABIOTECH
LOOKING FOR A SUPPLIER?